Alexion Pharma's (ALXN) ALXN1007 Granted EC Orphan Drug Designation as GVHD Treatment
Tweet Send to a Friend
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) announced that the European Commission has granted orphan drug designation (ODD) to ALXN1007, a novel ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
